Top Pharmaceuticals companies in United States by EBIT

This ranking features the top 670 Pharmaceuticals companies in United States ranked by EBIT, totalling a EBIT of USD 157.36 B, for January 15, 2025.

United States

Pharmaceuticals

#	Name	EBIT	Reported Date	Stock Price	Change	Country
1	UnitedHealth Group Incorporated 1 UNH	USD 22.69 B	Sept. 30, 2024	USD 543.74	0.48%	United States
2	Johnson & Johnson 2 JNJ	USD 22.23 B	Sept. 29, 2024	USD 144.75	0.19%	United States
3	AbbVie Inc. 3 ABBV	USD 15.88 B	Sept. 30, 2024	USD 175.55	-0.67%	United States
4	Merck & Co., Inc. 4 MRK	USD 14.97 B	Sept. 30, 2024	USD 99.65	-1.32%	United States
5	Eli Lilly and Company 5 LLY	USD 10.84 B	Sept. 30, 2024	USD 744.91	-6.59%	United States
6	CVS Health Corporation 6 CVS	USD 9.62 B	Sept. 30, 2024	USD 51.57	0.10%	United States
7	Thermo Fisher Scientific Inc. 7 TMO	USD 8.11 B	Sept. 28, 2024	USD 556.99	0.27%	United States
8	Abbott Laboratories 8 ABT	USD 7.53 B	Sept. 30, 2024	USD 113.02	-0.15%	United States
9	Amgen Inc. 9 AMGN	USD 7.47 B	Sept. 30, 2024	USD 267.10	-1.14%	United States
10	Pfizer Inc. 10 PFE	USD 6.94 B	Sept. 29, 2024	USD 26.41	-1.46%	United States
11	Cigna Corporation 11 CI	USD 6.42 B	Sept. 30, 2024	USD 285.03	0.91%	United States
12	Danaher Corporation 12 DHR	USD 4.91 B	Sept. 27, 2024	USD 237.62	-0.94%	United States
13	Colgate-Palmolive Company 13 CL	USD 4.65 B	Sept. 30, 2024	USD 87.67	0.65%	United States
14	Centene Corporation 14 CNC	USD 4.65 B	Sept. 30, 2024	USD 63.40	-0.47%	United States
15	Regeneron Pharmaceuticals, Inc. 15 REGN	USD 4.36 B	Sept. 30, 2024	USD 690.87	-3.63%	United States
16	McKesson Corporation 16 MCK	USD 4.17 B	Sept. 30, 2024	USD 593.73	1.48%	United States
17	Tenet Healthcare Corporation 17 THC	USD 3.46 B	Sept. 30, 2024	USD 127.63	-1.27%	United States
18	Zoetis Inc. 18 ZTS	USD 3.35 B	Sept. 30, 2024	USD 164.41	-1.15%	United States
19	GE HealthCare Technologies Inc. 19 GEHC	USD 2.99 B	Sept. 30, 2024	USD 84.13	-1.40%	United States
20	Humana Inc. 20 HUM	USD 2.80 B	Sept. 30, 2024	USD 282.63	-1.65%	United States
21	Becton, Dickinson and Company 21 BDX	USD 2.51 B	Sept. 30, 2024	USD 235.80	-0.17%	United States
22	Boston Scientific Corporation 22 BSX	USD 2.50 B	Sept. 30, 2024	USD 95.65	1.10%	United States
23	Biogen Inc. 23 BIIB	USD 2.27 B	Sept. 30, 2024	USD 143.06	-4.74%	United States
24	Cencora 24 COR	USD 2.23 B	Sept. 30, 2024	USD 240.05	1.68%	United States
25	IQVIA Holdings Inc. 25 IQV	USD 2.10 B	Sept. 30, 2024	USD 197.96	-3.26%	United States
26	Intuitive Surgical, Inc. 26 ISRG	USD 2.05 B	Sept. 30, 2024	USD 538.88	-0.16%	United States
27	Cardinal Health, Inc. 27 CAH	USD 1.85 B	Sept. 30, 2024	USD 124.03	2.62%	United States
28	DaVita Inc. 28 DVA	USD 1.85 B	Sept. 30, 2024	USD 162.00	3.15%	United States
29	Inhibrx Biosciences, Inc. 29 INBX	USD 1.65 B	Sept. 30, 2024	USD 12.74	-6.60%	United States
30	Edwards Lifesciences Corporation 30 EW	USD 1.55 B	Sept. 30, 2024	USD 71.04	-0.07%	United States
31	Agilent Technologies, Inc. 31 A	USD 1.54 B	Oct. 31, 2024	USD 143.43	1.04%	United States
32	Zimmer Biomet Holdings, Inc. 32 ZBH	USD 1.54 B	Sept. 30, 2024	USD 104.71	-0.74%	United States
33	ResMed Inc. 33 RMD	USD 1.47 B	Sept. 30, 2024	USD 228.83	-0.62%	United States
34	United Therapeutics Corporation 34 UTHR	USD 1.44 B	Sept. 30, 2024	USD 364.70	0.50%	United States
35	Organon & Co. 35 OGN	USD 1.43 B	Sept. 30, 2024	USD 15.81	0.96%	United States
36	Quest Diagnostics Incorporated 36 DGX	USD 1.31 B	Sept. 30, 2024	USD 152.98	-0.19%	United States
37	Solventum Corporation 37 SOLV	USD 1.25 B	Sept. 30, 2024	USD 70.19	2.45%	United States
38	Gilead Sciences, Inc. 38 GILD	USD 1.16 B	Sept. 30, 2024	USD 91.00	1.18%	United States
39	IDEXX Laboratories, Inc. 39 IDXX	USD 1.13 B	Sept. 30, 2024	USD 418.63	-0.94%	United States
40	Hologic, Inc. 40 HOLX	USD 987.20 M	Sept. 28, 2024	USD 70.20	-0.13%	United States
41	Waters Corporation 41 WAT	USD 851.20 M	Sept. 28, 2024	USD 404.93	1.26%	United States
42	Baxter International Inc. 42 BAX	USD 845.00 M	Sept. 30, 2024	USD 30.62	0.39%	United States
43	Laboratory Corporation of America Holdings 43 LH	USD 792.10 M	Sept. 30, 2024	USD 234.50	0.17%	United States
44	DexCom, Inc. 44 DXCM	USD 762.90 M	Sept. 30, 2024	USD 79.17	-0.84%	United States
45	Elanco Animal Health Incorporated 45 ELAN	USD 723.00 M	Sept. 30, 2024	USD 11.70	NA	United States
46	Royalty Pharma plc 46 RPRX	USD 717.71 M	Sept. 30, 2024	USD 30.03	0.13%	United States
47	Avantor, Inc. 47 AVTR	USD 689.70 M	Sept. 30, 2024	USD 21.72	-1.36%	United States
48	Charles River Laboratories International, Inc. 48 CRL	USD 650.21 M	Sept. 28, 2024	USD 178.08	-6.34%	United States
49	Exelixis, Inc. 49 EXEL	USD 608.28 M	Sept. 27, 2024	USD 35.65	0.99%	United States
50	West Pharmaceutical Services, Inc. 50 WST	USD 593.30 M	Sept. 30, 2024	USD 328.96	-3.13%	United States

1 2 3 4 … 14

Frequently Asked Questions

Which Pharmaceuticals company in United States has the highest EBIT ?

The Pharmaceuticals company in United States with the highest EBIT is UnitedHealth Group Incorporated (NYSE: UNH) at USD 22.69 B.
Which Pharmaceuticals company in United States has the lowest EBIT ?

The Pharmaceuticals company in United States with the lowest EBIT is Bristol-Myers Squibb Company (NYSE: BMY) at USD -5.11 B.

What are the top 10 Pharmaceuticals companies in United States by EBIT ?

The top 10 Pharmaceuticals companies in United States by EBIT are UnitedHealth Group Incorporated, Johnson & Johnson, AbbVie Inc., Merck & Co., Inc., Eli Lilly and Company, CVS Health Corporation, Thermo Fisher Scientific Inc., Abbott Laboratories, Amgen Inc. and Pfizer Inc..
What are the bottom 10 Pharmaceuticals companies in United States by EBIT ?

The bottom 10 Pharmaceuticals companies in United States by EBIT are Bristol-Myers Squibb Company, Albemarle Corporation, Moderna, Inc., QuidelOrtho Corporation, MultiPlan Corporation, Envista Holdings Corp, Bio-Rad Laboratories, Inc., Biohaven Pharmaceutical Holding Company Ltd., GRAIL, LLC and Insmed Incorporated.